13F HOLDINGS REPORT
Aquilo Capital Management, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001591986-23-000006
Total Value
$241.3M
Positions
12
Other Managers
0
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INVESCO QQQ TR | IVZ | 220,000 | $70.6M | 29.26% |
| 2 | BLUEPRINT MEDICINES CORP | 09627Y109 | 622,829 | $28.0M | 11.61% |
| 3 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 1,018,474 | $25.9M | 10.72% |
| 4 | MERUS N V | N5749R100 | 1,225,109 | $22.5M | 9.34% |
| 5 | KYMERA THERAPEUTICS INC | KYMR | 601,325 | $17.8M | 7.38% |
| 6 | ARVINAS INC | ARVN | 628,941 | $17.2M | 7.12% |
| 7 | REGENXBIO INC | RGNX | 831,014 | $15.7M | 6.51% |
| 8 | UNIQURE NV | QURE | 637,526 | $12.8M | 5.32% |
| 9 | GENMAB A/S | GNMSF | 242,848 | $9.2M | 3.80% |
| 10 | ARGENX SE | ARGX | 24,000 | $8.9M | 3.71% |
| 11 | SILENCE THERAPEUTICS PLC | SLNCF | 1,312,233 | $8.1M | 3.37% |
| 12 | PIERIS PHARMACEUTICALS INC | 720795103 | 4,552,876 | $4.4M | 1.84% |